Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematological Malignancy”

2,496 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,496 results

Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Early research (Phase 1)Study completedNCT01949545
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Solid TumorsHematologic MalignanciesHepatic Impairment
Amgen 46
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Not applicableUnknownNCT05566535
What this trial is testing

Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice

Who this might be right for
Polycythemia Vera
Multinational Center for Quality of Life Research, Russia 32
Not applicableEnrolling By InvitationNCT00001620
What this trial is testing

Screening for Hematology Branch Protocols

Who this might be right for
Hematologic Disease and DisordersDonorsHealthy Volunteer
National Heart, Lung, and Blood Institute (NHLBI) 10,000
Testing effectiveness (Phase 2)Ended earlyNCT04425655
What this trial is testing

Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.

Who this might be right for
Acute Myeloid Leukemia, AdultAMLAML, Adult
University of California, San Diego 2
Not applicableActive Not RecruitingNCT04650178
What this trial is testing

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 274
Large-scale testing (Phase 3)Study completedNCT00422890
What this trial is testing

Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndrome
Technische Universität Dresden 10
Testing effectiveness (Phase 2)Study completedNCT01491958
What this trial is testing

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Not applicableLooking for participantsNCT07203768
What this trial is testing

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Who this might be right for
Polycythemia VeraThrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 678
Testing effectiveness (Phase 2)Ended earlyNCT05348889
What this trial is testing

First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Who this might be right for
Non-Hodgkin's Lymphoma (disorder)Acute Lymphoid Leukemia, Disease (disorder)
Chimagen Biosciences, Ltd 7
Testing effectiveness (Phase 2)Looking for participantsNCT06462248
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

Who this might be right for
Lymphoma, NonhodgkinLeukemia, Lymphocytic
Chi Kong Li 20
Not applicableUnknownNCT03556748
What this trial is testing

WB-EMS and Nutrition in Patients With Hematological Malignancies

Who this might be right for
Hematologic DiseasesCachexia; CancerLeukemia+3 more
University of Erlangen-Nürnberg Medical School 40
Testing effectiveness (Phase 2)Study completedNCT00723099
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+23 more
Fred Hutchinson Cancer Center 73
Early research (Phase 1)WithdrawnNCT04605614
What this trial is testing

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02711852
What this trial is testing

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Who this might be right for
Hematologic Malignancy
SecuraBio 19
Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Early research (Phase 1)Looking for participantsNCT06615193
What this trial is testing

HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor

Who this might be right for
Advanced Solid TumorsRefractory LymphomaRelapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 111
Not applicableLooking for participantsNCT03680677
What this trial is testing

Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies

Who this might be right for
Leukemia, AcuteMDS
Abramson Cancer Center at Penn Medicine 20
Load More Results